Wallstreet Little Unchanged as Earnings, Coronavirus, take Centre Stage
Shares of drugmaker Eli Lilly and Co fell 6.9% after quarterly profits took a hit from increased costs to develop a COVID-19 treatment. A trial of its antibody therapy failed to show a benefit in...
Read moreDetails